Stockreport

Neuralstem Announces a 1-for-20 Reverse Stock Split

NEURALSTEM  (CUR) 
NASDAQ:AMEX Investor Relations: investor.neuralstem.com
PDF GERMANTOWN, Md., July 16, 2019 /PRNewswire/ -- Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company focused on developing novel treatments for nervous system dise [Read more]